HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression
dc.contributor.author | Pugliese, Alberto | |
dc.contributor.author | Boulware, David | |
dc.contributor.author | Yu, Liping | |
dc.contributor.author | Babu, Sunanda | |
dc.contributor.author | Steck, Andrea K. | |
dc.contributor.author | Becker, Dorothy | |
dc.contributor.author | Rodriguez, Henry | |
dc.contributor.author | DiMeglio, Linda | |
dc.contributor.author | Evans-Molina, Carmella | |
dc.contributor.author | Harrison, Leonard C. | |
dc.contributor.author | Schatz, Desmond | |
dc.contributor.author | Palmer, Jerry P. | |
dc.contributor.author | Greenbaum, Carla | |
dc.contributor.author | Eisenbarth, George S. | |
dc.contributor.author | Sosenko, Jay M. | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2020-02-10T13:16:49Z | |
dc.date.available | 2020-02-10T13:16:49Z | |
dc.date.issued | 2016-04 | |
dc.description.abstract | The HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 haplotype is linked to protection from the development of type 1 diabetes (T1D). However, it is not known at which stages in the natural history of T1D development this haplotype affords protection. We examined a cohort of 3,358 autoantibody-positive relatives of T1D patients in the Pathway to Prevention (PTP) Study of the Type 1 Diabetes TrialNet. The PTP study examines risk factors for T1D and disease progression in relatives. HLA typing revealed that 155 relatives carried this protective haplotype. A comparison with 60 autoantibody-negative relatives suggested protection from autoantibody development. Moreover, the relatives with DRB1*15:01-DQA1*01:02-DQB1*06:02 less frequently expressed autoantibodies associated with higher T1D risk, were less likely to have multiple autoantibodies at baseline, and rarely converted from single to multiple autoantibody positivity on follow-up. These relatives also had lower frequencies of metabolic abnormalities at baseline and exhibited no overall metabolic worsening on follow-up. Ultimately, they had a very low 5-year cumulative incidence of T1D. In conclusion, the protective influence of DRB1*15:01-DQA1*01:02-DQB1*06:02 spans from autoantibody development through all stages of progression, and relatives with this allele only rarely develop T1D. | en_US |
dc.identifier.citation | Pugliese, A., Boulware, D., Yu, L., Babu, S., Steck, A. K., Becker, D., … Type 1 Diabetes TrialNet Study Group (2016). HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression. Diabetes, 65(4), 1109–1119. doi:10.2337/db15-1105 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/22032 | |
dc.language.iso | en_US | en_US |
dc.publisher | American Diabetes Association | en_US |
dc.relation.isversionof | 10.2337/db15-1105 | en_US |
dc.relation.journal | Diabetes | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | Autoantibodies | en_US |
dc.subject | Diabetes Complications | en_US |
dc.subject | Diabetes Mellitus, Type 1 | en_US |
dc.subject | Genetic Predisposition to Disease | en_US |
dc.subject | HLA-DQ beta-Chains | en_US |
dc.title | HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression | en_US |
dc.type | Article | en_US |